Mauritius Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mauritius Healthcare Daily.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on January 27, 2026

Jan. 27, 2026

CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer

GlobeNewswire

Jan. 27, 2026

NewGen to Execute Up to US$2 Million Share Repurchase Program Through Benchmark

GlobeNewswire

Jan. 27, 2026

Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering

GlobeNewswire

Jan. 27, 2026

ABLi Therapeutics Completes Collaboration Agreement with The Michael J. Fox Foundation to include Risvodetinib in Path to Prevention Platform Trial

GlobeNewswire

Jan. 27, 2026

Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’

GlobeNewswire

Jan. 27, 2026

Science 37 Appoints Kelly Johnston McKee as VP of Strategy & Transformation

GlobeNewswire

Jan. 27, 2026

Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026

GlobeNewswire

Jan. 27, 2026

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

GlobeNewswire

Jan. 27, 2026

Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN

GlobeNewswire

Jan. 27, 2026

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide

GlobeNewswire

Jan. 27, 2026

Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada

GlobeNewswire

Jan. 27, 2026

Cloudbreak Pharma Announces Successful End-of-Phase-2 Meeting and Alignment with FDA on Phase 3 Path Forward for CBT-004

GlobeNewswire

Jan. 27, 2026

Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)

GlobeNewswire

Jan. 27, 2026

Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)

GlobeNewswire

Jan. 27, 2026

Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies

GlobeNewswire

Jan. 27, 2026

Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics

GlobeNewswire

Jan. 27, 2026

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

GlobeNewswire

Jan. 27, 2026

Cytokinetics Announces MYQORZO™ (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

GlobeNewswire

Jan. 27, 2026

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

GlobeNewswire

Jan. 27, 2026

Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC

GlobeNewswire